Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Keratosis, Seborrheic × Gels × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 12 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Squamous Intraepithelial Lesions 1 Skin Neoplasms 1 Parapsoriasis 1 Non-Melanoma Skin Cancers 1 Keratosis, Seborrheic 1 Dermatitis, Contact 1 Carcinoma, Squamous Cell 1

Interventions

Ultrasonography, Doppler 1 Tomography, Optical Coherence 1 Gels 1 3-ingenyl angelate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01214564 2011-01-25

Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic Keratosis

Peplin

Phase 2 Completed

Keratosis, Seborrheic, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡